BACKGROUND: Cardiac disease is a significant cause of morbidity and mortality in children with end-stage renal disease (ESRD). This study aimed to report the frequency of cardiac disease diagnostic methods used in US pediatric maintenance hemodialysis patients. METHODS: A cross-sectional analysis of all US pediatric (ages 0.7-18 years, n = 656) maintenance hemodialysis patients was performed using data from the Centers for Medicare and Medicaid Services ESRD Clinical Performance Measures Project. Clinical and laboratory information was collected in 2001. Results were analysed by age, sex, race, Hispanic ethnicity, dialysis duration, body mass index (BMI), primary ESRD cause and laboratory data. RESULTS: Ninety-two percent of the patients had a cardiovascular risk factor (63% hypertension, 38% anemia, 11% BMI > 94th percentile, 63% serum phosphorus > 5.5 mg/dL and 55% calcium-phosphorus product ≥ 55 mg(2)/dL(2)). A diagnosis of cardiac disease was reported in 24% (n = 155) of all patients: left ventricular hypertrophy/enlargement 17%, congestive heart failure/pulmonary edema 8%, cardiomyopathy 2% and decreased left ventricular function 2%. Thirty-one percent of patients were not tested. Of those tested, the diagnostic methods used were chest X-rays in 60%, echocardiograms in 35% and electrocardiograms in 33%; left ventricular hypertrophy/enlargement was diagnosed using echocardiogram (72%), chest X-ray (20%) and electrocardiogram (15%). CONCLUSIONS: Although 92% of patients had cardiovascular risk factors, an echocardiography was performed in only one-third of the patients. Our study raises the question of why echocardiography, considered the gold standard for cardiac disease diagnosis, has been infrequently used in pediatric maintenance dialysis patients, a high-risk patient population.
BACKGROUND:Cardiac disease is a significant cause of morbidity and mortality in children with end-stage renal disease (ESRD). This study aimed to report the frequency of cardiac disease diagnostic methods used in US pediatric maintenance hemodialysis patients. METHODS: A cross-sectional analysis of all US pediatric (ages 0.7-18 years, n = 656) maintenance hemodialysis patients was performed using data from the Centers for Medicare and Medicaid Services ESRD Clinical Performance Measures Project. Clinical and laboratory information was collected in 2001. Results were analysed by age, sex, race, Hispanic ethnicity, dialysis duration, body mass index (BMI), primary ESRD cause and laboratory data. RESULTS: Ninety-two percent of the patients had a cardiovascular risk factor (63% hypertension, 38% anemia, 11% BMI > 94th percentile, 63% serum phosphorus > 5.5 mg/dL and 55% calcium-phosphorus product ≥ 55 mg(2)/dL(2)). A diagnosis of cardiac disease was reported in 24% (n = 155) of all patients: left ventricular hypertrophy/enlargement 17%, congestive heart failure/pulmonary edema 8%, cardiomyopathy 2% and decreased left ventricular function 2%. Thirty-one percent of patients were not tested. Of those tested, the diagnostic methods used were chest X-rays in 60%, echocardiograms in 35% and electrocardiograms in 33%; left ventricular hypertrophy/enlargement was diagnosed using echocardiogram (72%), chest X-ray (20%) and electrocardiogram (15%). CONCLUSIONS: Although 92% of patients had cardiovascular risk factors, an echocardiography was performed in only one-third of the patients. Our study raises the question of why echocardiography, considered the gold standard for cardiac disease diagnosis, has been infrequently used in pediatric maintenance dialysis patients, a high-risk patient population.
Authors: Jaap W Groothoff; Mariken P Gruppen; Martin Offringa; Jeroen Hutten; Marc R Lilien; Nicole J Van De Kar; Eric D Wolff; Jean Claude Davin; Hugo S A Heymans Journal: Kidney Int Date: 2002-02 Impact factor: 10.612
Authors: M Litwin; R Grenda; S Prokurat; M Abuauba; J Latoszyñska; K Jobs; A Boguszewska-Baczkowska; Z T Wawer Journal: Pediatr Nephrol Date: 2001-12 Impact factor: 3.714
Authors: Mariken P Gruppen; Jaap W Groothoff; Martin Prins; Poll van der Wouw; Martin Offringa; Willem Jan Bos; Jean Claude Davin; Hugo S A Heymans Journal: Kidney Int Date: 2003-03 Impact factor: 10.612
Authors: Blanche M Chavers; Craig A Solid; Frank X Daniels; Shu-Cheng Chen; Allan J Collins; Diane L Frankenfield; Charles A Herzog Journal: Clin J Am Soc Nephrol Date: 2009-06-25 Impact factor: 8.237
Authors: Sandeep K Riar; Mark M Mitsnefes; Edward J Nehus; Hiren P Patel; Julia M Steinke; Teri Crumb; Elizabeth C Abraham; Margret W Kamel; Larry A Greenbaum Journal: Pediatr Nephrol Date: 2015-03-08 Impact factor: 3.714
Authors: Blanche M Chavers; Julia T Molony; Craig A Solid; Michelle N Rheault; Allan J Collins Journal: Am J Nephrol Date: 2015-03-07 Impact factor: 3.754
Authors: Nikki J Schoenmaker; Johanna H van der Lee; Jaap W Groothoff; Gabrielle G van Iperen; Ingrid M E Frohn-Mulder; Ronald B Tanke; Jaap Ottenkamp; Irene M Kuipers Journal: BMC Nephrol Date: 2013-08-02 Impact factor: 2.388
Authors: Marcin Tkaczyk; Małgorzata Stańczyk; Monika Miklaszewska; Katarzyna Zachwieja; Ryszard Wierciński; Roman Stankiewicz; Agnieszka Firszt-Adamczyk; Jacek Zachwieja; Halina Borzęcka; Ilona Zagożdżon; Beata Leszczyńska; Anna Medyńska; Piotr Adamczyk; Maria Szczepańska; Wojciech Fendler Journal: Ren Fail Date: 2016-11-24 Impact factor: 2.606